Status:
UNKNOWN
Using Embryo Organoids to Discover Human-specific Mechanisms of Preimplantation Embryo Development and Early Pregnancy
Lead Sponsor:
University Hospital, Montpellier
Conditions:
Infertility
Eligibility:
FEMALE
18-50 years
Brief Summary
EMBRYOx study aims to establish and validate the use of trophoblast organoids (embryoids) from trophoblast placental stem cells as a 3D research model in understanding further preimplantation embryo d...
Detailed Description
Study objectives: Our primary objective is to compare the transcriptomic profiles of embryoids with those obtained from human embryos donated to research and cultured in two different oxygen conditio...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- \- No smoking patients without drug consumption or previous medication who are having first trimester voluntary termination of pregnancy surgically or medically induced.
- Exclusion criteria:
- \- Patients smoking, drug consumption, previous medication
Exclusion
Key Trial Info
Start Date :
February 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
February 28 2024
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT05231551
Start Date
February 1 2022
End Date
February 28 2024
Last Update
February 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295